Coloplast A/S B Forecast, price target & analysts
Coloplast A/S B Target price 2026 - Analyst rating & recommendation
Coloplast A/S B Classifications & Recommendation:
Coloplast A/S B Price Target
| Target Price | kr678.30 |
| Price | kr536.40 |
| Potential |
26.45%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Coloplast A/S B 2027 .
The average Coloplast A/S B target price is kr678.30.
This is
26.45%
register free of charge
kr840.00
56.60%
register free of charge
kr546.41
1.87%
register free of charge
|
|
| A rating was issued by 26 analysts: 9 Analysts recommend Coloplast A/S B to buy, 15 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2027 of
26.45%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 27.87 | 29.68 |
| 3.12% | 6.46% | |
| EBITDA Margin | 30.42% | 32.55% |
| 1.89% | 7.01% | |
| Net Margin | 13.04% | 19.80% |
| 30.21% | 51.79% |
23 Analysts have issued a sales forecast Coloplast A/S B 2026 . The average Coloplast A/S B sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Coloplast A/S B EBITDA forecast 2026. The average Coloplast A/S B EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 Coloplast A/S B Analysts have issued a net profit forecast 2026. The average Coloplast A/S B net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 16.13 | 26.07 |
| 28.18% | 61.62% | |
| P/E | 20.57 | |
| EV/Sales | 4.87 |
23 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B EPS is
This results in the following potential growth metrics and future valuations:
Coloplast A/S B...
Current Coloplast A/S B Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| JYSKE BANK |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
JYSKE BANK:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Sep 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
